Prevalence of Angle Closure in Caucasian Hyperopes

Chronic Angle Closure Glaucoma Clinical Trial

Official title:

Prevalence of Chronic Angle Closure in Caucasian Hyperopic Subjects

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00823706
• Other study ID #: 122/08
• Status: Recruiting
• Phase: N/A
• First received: January 15, 2009
• Last updated: April 4, 2011
• Start date: January 2009

Study information

• Verified date: January 2009
• Source: Assaf-Harofeh Medical Center
• Contact: yaniv barkana, md
• Phone: 97289779358
• Email: yanivbarkana[@]gmail.com
• Is FDA regulated: No
• Health authority: Israel: Ministry of Health
• Study type: Observational

Clinical Trial Summary

The primary purpose of this study is to assess the prevalence of asymptomatic chronic angle closure in high risk Caucasian individuals, namely those with hyperopia. A secondary purpose is to assess whether specific demographic or ocular-anatomic parameters in this population are associated with a higher risk for angle closure.

Description:

Caucasian subjects aged > 40 years with hyperopia will undergo complete eye examination including subjective refraction and gonioscopy. In addition we will measure axial length, anterior chamber depth and lens thickness using ultrasound biometry.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 100
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Age greater than 40 years

• Hyperopia greater then +1.00 D spherical equivalent

Exclusion Criteria:

• Any identifiable eye disease or previous eye surgery that can affect the anatomy of the irido-corneal angle

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Chronic Angle Closure Glaucoma
• Glaucoma, Angle-Closure

Locations

Country	Name	City	State
Israel	Assaf Harofe Medical Center Ophthalmology Department	Zerifin

Sponsors (1)

Lead Sponsor	Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	prevalence of chronic angle closure in Caucasian hyperopes		1 year	No
Secondary	relative risk for chronic angle closure measured for demographic and ocular-anatomic parameters		1 year	No